(0.22%) 5 533.50 points
(0.15%) 39 529 points
(0.24%) 19 974 points
(0.67%) $82.09
(-2.04%) $2.55
(0.15%) $2 343.10
(0.19%) $29.62
(-0.56%) $996.30
(-0.27%) $0.931
(-0.26%) $10.65
(-0.14%) $0.790
(1.95%) $87.40
Live Chart Being Loaded With Signals
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform...
Stats | |
---|---|
今日成交量 | 1.75M |
平均成交量 | 263 314 |
市值 | 2.33M |
EPS | $-3.60 ( Q4 | 2023-03-20 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0194 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.141 (69.42%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-05 | Lau Johnson Yiu Nam | Buy | 8 382 | Common Stock |
2023-05-05 | Kwan Rudolf | Buy | 3 603 | Common Stock |
2023-05-05 | Cook Timothy Devere | Buy | 368 | Common Stock |
2023-04-21 | Wu Jinn | Buy | 6 513 | Common Stock |
2023-04-21 | Vierling John | Buy | 6 513 | Common Stock |
INSIDER POWER |
---|
96.27 |
Last 100 transactions |
Buy: 1 577 577 | Sell: 76 746 |
音量 相关性
Athenex Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Athenex Inc 相关性 - 货币/商品
Athenex Inc 财务报表
Annual | 2022 |
营收: | $102.82M |
毛利润: | $26.70M (25.97 %) |
EPS: | $-15.13 |
FY | 2022 |
营收: | $102.82M |
毛利润: | $26.70M (25.97 %) |
EPS: | $-15.13 |
FY | 2021 |
营收: | $120.18M |
毛利润: | $37.78M (31.43 %) |
EPS: | $-1.920 |
FY | 2020 |
营收: | $144.39M |
毛利润: | $49.04M (33.96 %) |
EPS: | $-1.720 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Athenex Inc
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar, an oral dosage form, which is in Phase III trial for metastatic breast cancer, as well as various clinical studies in cutaneous angiosarcoma, advanced gastric cancer, and advanced solid malignancies. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis. In addition, the company is developing KUR-501, an autologous product that is in a phase I clinical trial for treating children with relapsed-refractory (R/R) high risk neuroblastoma; KUR-502, an allogeneic product, which is in a phase I clinical trial for treating adults with R/R CD19 positive malignancies, including B cell lymphoma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia; and KUR-503, an allogeneic product that is in preclinical development for advanced hepatocellular carcinomas, as well as TCRT-ESO-A2, an autologous T cell receptor (TCR)-T cell therapy that is in phase 1 clinical trial for solid tumors. Further, it is developing dual absorption enhancers to inhibit the P-gp transporter and the cytochrome p450 3A enzymes within the gastrointestinal tract; and has a portfolio of TCRs that recognize hotspot mutations in p53, KRAS, and EGFR genes for multiple tumors. The company was formerly known as Kinex Pharmaceuticals LLC and changed its name to Athenex, Inc. in August 2015. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。